Skip to main content
Top
Published in: Lasers in Medical Science 4/2014

01-07-2014 | Original Article

Apoptosis-associated genes related to photodynamic therapy in breast carcinomas

Authors: J. C. Silva, J. Ferreira-Strixino, L. C. Fontana, L. M. Paula, L. Raniero, A. A. Martin, R. A. Canevari

Published in: Lasers in Medical Science | Issue 4/2014

Login to get access

Abstract

The aim of this study was to find the apoptosis molecular markers involved in the cell death that might be related to photodynamic therapy (PDT) mechanisms in breast cancer. The mammary tumors were induced in 25 Sprague-Dawley female rats by a single, oral gavage of 7,12-dimethylbenz(a)anthracene (DMBA; 70 mg/kg body weight). Animals were divided into four groups: G1 (normal, without DMBA), G2 (control, without PDT treatment), G3 (euthanized 48 h after PDT), and G4 (euthanized 24 h after PDT). For PDT experiments, the photosensitizer used was Photodithazine, and 100 J/cm of light at a fluence rate of 100 mW/cm was delivered to treat lesions. A sample of each animal was investigated by quantitative real-time PCR using Rat Apoptosis RT2 Profiler™ PCR Array platform. The results showed 20 genes with differential expression between PDT and control groups. A significant upregulation was observed for pro-apoptotic genes CASP4, CASP12, CIDEA, GADD45A, and FAS and downregulation of anti-apoptotic genes MAPK8IP1, TNFRSF11B, and NAIP2 in PDT-treated tumors. These results indicate that these genes are more directly involved in cell apoptosis induced by PDT.
Literature
1.
2.
go back to reference Yoshida R, Niki M, Jyotaki M, Sanematsu K et al (2012) Modulation of sweet responses of taste receptor cells. Semin Cell Dev Biol 25:812–826 Yoshida R, Niki M, Jyotaki M, Sanematsu K et al (2012) Modulation of sweet responses of taste receptor cells. Semin Cell Dev Biol 25:812–826
4.
go back to reference Araujo NC, Fontana CR, Bagnato VS et al (2012) Photodynamic effects of curcumin against cariogenic pathogens. Photomed Laser Surg 30:393–399PubMedCrossRef Araujo NC, Fontana CR, Bagnato VS et al (2012) Photodynamic effects of curcumin against cariogenic pathogens. Photomed Laser Surg 30:393–399PubMedCrossRef
5.
go back to reference Ferraz RCMC, Ferreira J, Menezes PFC et al (2009) Determination of thereshold dose of photodynamic to measure superficial necrosis. Photomed Laser Surg 27:97–99CrossRef Ferraz RCMC, Ferreira J, Menezes PFC et al (2009) Determination of thereshold dose of photodynamic to measure superficial necrosis. Photomed Laser Surg 27:97–99CrossRef
6.
go back to reference Almeida RD, Manadas BJ, Carvalho AP et al (2004) Intracellular signaling mechanisms in photodynamic therapy. Biochim Biophys Acta 1704:59–86PubMed Almeida RD, Manadas BJ, Carvalho AP et al (2004) Intracellular signaling mechanisms in photodynamic therapy. Biochim Biophys Acta 1704:59–86PubMed
7.
go back to reference Plonka J, Latocha M (2012) Photodynamic therapy in the treatment of breast cancer. Pol Merkur Lekarski 33:173–175PubMed Plonka J, Latocha M (2012) Photodynamic therapy in the treatment of breast cancer. Pol Merkur Lekarski 33:173–175PubMed
8.
go back to reference Matroule JY, Carthy CM, Granville DJ, Jolois O, Hunt DWC, Piette J (2001) Mechanism of colon cancer cell apoptosis mediated by pyropheophorbide-a methylester photosensitization. Oncogene 20:4070–4084PubMedCrossRef Matroule JY, Carthy CM, Granville DJ, Jolois O, Hunt DWC, Piette J (2001) Mechanism of colon cancer cell apoptosis mediated by pyropheophorbide-a methylester photosensitization. Oncogene 20:4070–4084PubMedCrossRef
9.
go back to reference Wild PJ, Krieg RC, Seidl J et al (2005) RNA expression profiling of normal and tumor cells following photodynamic therapy with 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Mol Cancer Ther 4:516–528PubMedCrossRef Wild PJ, Krieg RC, Seidl J et al (2005) RNA expression profiling of normal and tumor cells following photodynamic therapy with 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Mol Cancer Ther 4:516–528PubMedCrossRef
10.
go back to reference Romanko YS, Tsyb AF, Kaplan MA, Popuchiev VV (2004) Effect of photodynamic therapy with Photodithazine on morphofunctional parameters of M-1 sarcoma. Bulletin of experimental biology and medicine 138:584–589PubMedCrossRef Romanko YS, Tsyb AF, Kaplan MA, Popuchiev VV (2004) Effect of photodynamic therapy with Photodithazine on morphofunctional parameters of M-1 sarcoma. Bulletin of experimental biology and medicine 138:584–589PubMedCrossRef
11.
go back to reference Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408 Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408
12.
go back to reference Xu B, Zhou Y, OK, Choy PC et al (2010) Regulation of stress-associated scaffold proteins JIP1 and JIP3 on the c-Jun NH2-terminal kinase in ischemia-reperfusion. Can J Physiol Pharmacol 88:1084–1092PubMedCrossRef Xu B, Zhou Y, OK, Choy PC et al (2010) Regulation of stress-associated scaffold proteins JIP1 and JIP3 on the c-Jun NH2-terminal kinase in ischemia-reperfusion. Can J Physiol Pharmacol 88:1084–1092PubMedCrossRef
13.
go back to reference Duanmu J, Cheng J, Xu J et al (2011) Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-target photodynamic therapy. Br J Cancer 104:1401–1409PubMedCentralPubMedCrossRef Duanmu J, Cheng J, Xu J et al (2011) Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-target photodynamic therapy. Br J Cancer 104:1401–1409PubMedCentralPubMedCrossRef
14.
go back to reference Cekaite L, Peng Q, Reiner A et al (2007) Mapping of oxidative stress responses of human tumor cells following photodynamic therapy using hexaminolevulinate. BMC Genomics 8:273–293PubMedCentralPubMedCrossRef Cekaite L, Peng Q, Reiner A et al (2007) Mapping of oxidative stress responses of human tumor cells following photodynamic therapy using hexaminolevulinate. BMC Genomics 8:273–293PubMedCentralPubMedCrossRef
15.
go back to reference Tsujimoto Y (2003) Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 195:158–167PubMedCrossRef Tsujimoto Y (2003) Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 195:158–167PubMedCrossRef
17.
go back to reference Kessel D, Castelli M (2001) Evidence that bcl-2 is the target of three photosensitizers that induce a rapid apoptotic response. Photochem Photobiol 74:318–322 Kessel D, Castelli M (2001) Evidence that bcl-2 is the target of three photosensitizers that induce a rapid apoptotic response. Photochem Photobiol 74:318–322
18.
go back to reference Peng Q, Moan J, Nesland JM (1996) Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. Ultrastruct Pathol 20:109–129PubMedCrossRef Peng Q, Moan J, Nesland JM (1996) Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. Ultrastruct Pathol 20:109–129PubMedCrossRef
19.
go back to reference Luo Y, Kessel D (1997) Initiation of apoptosis versus necrosis by photodynamic therapy with chloroaluminum phthalocyanine. Photochem Photobiol 66:479–483PubMedCrossRef Luo Y, Kessel D (1997) Initiation of apoptosis versus necrosis by photodynamic therapy with chloroaluminum phthalocyanine. Photochem Photobiol 66:479–483PubMedCrossRef
20.
go back to reference Graham A, Li G, Chen Y et al (2003) Structure–activity relationship of new octaethylporphyrin-based benzochlorins as photosensitizers for photodynamic therapy. Photochem Photobiol 77:561–566PubMed Graham A, Li G, Chen Y et al (2003) Structure–activity relationship of new octaethylporphyrin-based benzochlorins as photosensitizers for photodynamic therapy. Photochem Photobiol 77:561–566PubMed
21.
go back to reference Fontana CR, Lerman MA, Patel N et al (2012) Safety assessment of oral photodynamic therapy in rats. Lasers Med Sci 12:1091–1096 Fontana CR, Lerman MA, Patel N et al (2012) Safety assessment of oral photodynamic therapy in rats. Lasers Med Sci 12:1091–1096
22.
23.
go back to reference Wainwright M (2008) Photodynamic therapy: the development of new photosensitisers. Anticancer Agents Med Chem 8:280–291PubMedCrossRef Wainwright M (2008) Photodynamic therapy: the development of new photosensitisers. Anticancer Agents Med Chem 8:280–291PubMedCrossRef
24.
go back to reference Trushina OI, Novikova EG, Sokolov VV et al (2008) Photodynamic therapy of virus-associated precancer and early stages cancer of cervix uteri. Photodiagnosis Photodyn Ther 5:256–259PubMedCrossRef Trushina OI, Novikova EG, Sokolov VV et al (2008) Photodynamic therapy of virus-associated precancer and early stages cancer of cervix uteri. Photodiagnosis Photodyn Ther 5:256–259PubMedCrossRef
25.
go back to reference Filonenko EV, Sokolov VV, Chissov VI et al (2008) Photodynamic therapy of early esophageal cancer. Photodiagnosis Photodyn Ther 5:187–190PubMedCrossRef Filonenko EV, Sokolov VV, Chissov VI et al (2008) Photodynamic therapy of early esophageal cancer. Photodiagnosis Photodyn Ther 5:187–190PubMedCrossRef
26.
go back to reference Wen LY, Bae S, Chun H et al (2012) Therapeutic effects of systemic photodynamic therapy in a leukemia animal model using A20 cells. Lasers Med Sci 27:445–452PubMedCrossRef Wen LY, Bae S, Chun H et al (2012) Therapeutic effects of systemic photodynamic therapy in a leukemia animal model using A20 cells. Lasers Med Sci 27:445–452PubMedCrossRef
27.
go back to reference Engström W, Granerus M (2009) Expression of JNK-interacting protein JIP-1 and insulin-like growth factor II in Wilms tumour cell lines and primary Wilms tumours. Anticancer Res 29:2467–2472PubMed Engström W, Granerus M (2009) Expression of JNK-interacting protein JIP-1 and insulin-like growth factor II in Wilms tumour cell lines and primary Wilms tumours. Anticancer Res 29:2467–2472PubMed
28.
go back to reference Xia Z, Dickens M, Raingeaud J et al (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326–1331PubMedCrossRef Xia Z, Dickens M, Raingeaud J et al (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326–1331PubMedCrossRef
29.
go back to reference Donovan N, Becker EB, Konishi Y et al (2002) JNK phosphorylation and activation of BAD couples the stress activated signalling pathway to the cell death machinery. J Biol Chem 277:40944–40949PubMedCrossRef Donovan N, Becker EB, Konishi Y et al (2002) JNK phosphorylation and activation of BAD couples the stress activated signalling pathway to the cell death machinery. J Biol Chem 277:40944–40949PubMedCrossRef
30.
go back to reference Nishina H, Vaz C, Billia P et al (1999) Defective liver formation and liver cell apoptosis in mice lacking the stress signalling kinase SEK1/MKK4. Development 126:505–516PubMed Nishina H, Vaz C, Billia P et al (1999) Defective liver formation and liver cell apoptosis in mice lacking the stress signalling kinase SEK1/MKK4. Development 126:505–516PubMed
31.
go back to reference Selivanova G, Wiman KG (1995) p53: a cell cycle regulator activated by DNA damage. Adv Cancer Res 66:143–175PubMedCrossRef Selivanova G, Wiman KG (1995) p53: a cell cycle regulator activated by DNA damage. Adv Cancer Res 66:143–175PubMedCrossRef
32.
go back to reference Lee SY, Luk SK, Chuang CP et al (2010) TP53 regulates human AlkB homologue 2 expression in glioma resistance to Photofrin-mediated photodynamic therapy. Br J Cancer 103:362–369PubMedCentralPubMedCrossRef Lee SY, Luk SK, Chuang CP et al (2010) TP53 regulates human AlkB homologue 2 expression in glioma resistance to Photofrin-mediated photodynamic therapy. Br J Cancer 103:362–369PubMedCentralPubMedCrossRef
33.
go back to reference Fisher AMR, Ferrario A, Rucker N et al (1999) Photodynamic therapy sensitivity is not altered in human tumor cells after abrogation of p53 function. Cancer Res 59:331–335PubMed Fisher AMR, Ferrario A, Rucker N et al (1999) Photodynamic therapy sensitivity is not altered in human tumor cells after abrogation of p53 function. Cancer Res 59:331–335PubMed
34.
go back to reference Wyld L, Reed MWR, Brown NJ (2001) Differential cell death response to photodynamic therapy is dependent on dose and cell type. Br J Cancer 84:1384–1386PubMedCentralPubMedCrossRef Wyld L, Reed MWR, Brown NJ (2001) Differential cell death response to photodynamic therapy is dependent on dose and cell type. Br J Cancer 84:1384–1386PubMedCentralPubMedCrossRef
35.
go back to reference Tsukamoto S, Ishikawa T, Lida S et al (2011) Clinical significance of osteoprotegerin expression in human colorectal cancer. Clin Cancer Res 17:2444–2450PubMedCrossRef Tsukamoto S, Ishikawa T, Lida S et al (2011) Clinical significance of osteoprotegerin expression in human colorectal cancer. Clin Cancer Res 17:2444–2450PubMedCrossRef
36.
go back to reference Wiley SR, Schooley K, Smolak PJ et al (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673–682PubMedCrossRef Wiley SR, Schooley K, Smolak PJ et al (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673–682PubMedCrossRef
37.
go back to reference Sprick MR, Weigand MA, Rieser E et al (2000) FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12:599–609PubMedCrossRef Sprick MR, Weigand MA, Rieser E et al (2000) FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12:599–609PubMedCrossRef
39.
go back to reference Wischhusen J, Schneider D, Mittelbronn M et al (2005) Death receptor-mediated apoptosis in human malignant glioma cells: modulation by the CD40/CD40L system. J Neuroimmunol 162:28–42PubMedCrossRef Wischhusen J, Schneider D, Mittelbronn M et al (2005) Death receptor-mediated apoptosis in human malignant glioma cells: modulation by the CD40/CD40L system. J Neuroimmunol 162:28–42PubMedCrossRef
40.
go back to reference Fiandalo MV, Kyprianou N (2012) Caspase control: protagonists of cancer cell apoptosis. Experimental oncology 34:165–175PubMedCentralPubMed Fiandalo MV, Kyprianou N (2012) Caspase control: protagonists of cancer cell apoptosis. Experimental oncology 34:165–175PubMedCentralPubMed
41.
go back to reference Ahmad N, Gupta S, Feyes DK, Mukhtar H (2000) Involvement of Fas (APO-1/CD-95) during photodynamic-therapy-mediated apoptosis in human epidermoid carcinoma A431 cells. J Invest Dermatol 115:1041–1046PubMedCrossRef Ahmad N, Gupta S, Feyes DK, Mukhtar H (2000) Involvement of Fas (APO-1/CD-95) during photodynamic-therapy-mediated apoptosis in human epidermoid carcinoma A431 cells. J Invest Dermatol 115:1041–1046PubMedCrossRef
42.
go back to reference Omae N, Ito M, Hase S et al (2012) Suppression of FoxO1/cell death-inducing DNA fragmentation factor a-like effector A (Cidea) axis protects mouse b-cells against palmitic acid-induced apoptosis. Mol Cell Endocrinol 348:297–304PubMedCrossRef Omae N, Ito M, Hase S et al (2012) Suppression of FoxO1/cell death-inducing DNA fragmentation factor a-like effector A (Cidea) axis protects mouse b-cells against palmitic acid-induced apoptosis. Mol Cell Endocrinol 348:297–304PubMedCrossRef
43.
go back to reference Valousková E, Smolková K, Santorová J et al (2008) Redistribution of cell death-inducing DNA fragmentation factor-like effector-a (CIDEa) from mitochondria to nucleus is associated with apoptosis in HeLa cells. Gen Physiol Biophys 27:92–100PubMed Valousková E, Smolková K, Santorová J et al (2008) Redistribution of cell death-inducing DNA fragmentation factor-like effector-a (CIDEa) from mitochondria to nucleus is associated with apoptosis in HeLa cells. Gen Physiol Biophys 27:92–100PubMed
Metadata
Title
Apoptosis-associated genes related to photodynamic therapy in breast carcinomas
Authors
J. C. Silva
J. Ferreira-Strixino
L. C. Fontana
L. M. Paula
L. Raniero
A. A. Martin
R. A. Canevari
Publication date
01-07-2014
Publisher
Springer London
Published in
Lasers in Medical Science / Issue 4/2014
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-014-1547-y

Other articles of this Issue 4/2014

Lasers in Medical Science 4/2014 Go to the issue